Equities researchers at BMO Capital Markets began coverage on shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in a research note issued on Monday. The brokerage set an “outperform” rating on the stock.
A number of other research analysts also recently commented on ACHC. Jefferies Group LLC set a $60.00 price target on shares of Acadia Healthcare and gave the company a “buy” rating in a report on Wednesday, October 11th. Craig Hallum reaffirmed a “buy” rating and issued a $65.00 price target (up previously from $52.00) on shares of Acadia Healthcare in a report on Monday, July 31st. Zacks Investment Research downgraded shares of Acadia Healthcare from a “buy” rating to a “hold” rating in a report on Tuesday, August 1st. UBS AG reaffirmed a “positive” rating and issued a $60.00 price target (up previously from $54.00) on shares of Acadia Healthcare in a report on Monday, July 31st. Finally, BidaskClub downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Friday, August 18th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $57.40.
Acadia Healthcare (NASDAQ:ACHC) traded down 0.38% during midday trading on Monday, reaching $41.56. The company had a trading volume of 677,366 shares. The firm has a 50-day moving average price of $46.12 and a 200-day moving average price of $46.36. The company has a market capitalization of $3.65 billion, a price-to-earnings ratio of 456.70 and a beta of 1.07. Acadia Healthcare has a 52 week low of $32.54 and a 52 week high of $54.34.
Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Thursday, July 27th. The company reported $0.66 EPS for the quarter, beating the Zacks’ consensus estimate of $0.65 by $0.01. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. The firm had revenue of $715.90 million during the quarter, compared to the consensus estimate of $717.38 million. During the same quarter last year, the firm earned $0.73 EPS. The firm’s revenue for the quarter was down 5.4% compared to the same quarter last year. Analysts expect that Acadia Healthcare will post $2.45 EPS for the current fiscal year.
In other news, President Brent Turner sold 206,252 shares of the firm’s stock in a transaction that occurred on Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total transaction of $10,454,913.88. Following the transaction, the president now directly owns 81,106 shares of the company’s stock, valued at $4,111,263.14. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Reeve B. Waud sold 1,240,000 shares of the firm’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $51.72, for a total transaction of $64,132,800.00. The disclosure for this sale can be found here. Insiders sold a total of 3,085,693 shares of company stock worth $157,729,099 over the last three months. 11.10% of the stock is currently owned by corporate insiders.
Several large investors have recently modified their holdings of ACHC. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Acadia Healthcare by 11.1% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock worth $134,000 after acquiring an additional 270 shares during the period. C M Bidwell & Associates Ltd. purchased a new position in shares of Acadia Healthcare during the second quarter worth approximately $205,000. Riverhead Capital Management LLC purchased a new position in shares of Acadia Healthcare during the second quarter worth approximately $209,000. Paloma Partners Management Co purchased a new position in shares of Acadia Healthcare during the first quarter worth approximately $217,000. Finally, M&T Bank Corp purchased a new position in shares of Acadia Healthcare during the first quarter worth approximately $230,000.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.